Trichostatin A Inhibits Retinal Pigmented Epithelium Activation in an In Vitro Model of Proliferative Vitreoretinopathy
Open Access
- 5 August 2016
- journal article
- research article
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 32 (7) , 415-424
Abstract
Purpose: Proliferative vitreoretinopathy (PVR) is a blinding disorder that develops after a retinal tear or detachment. Activation of the retinal pigmented epithelium (RPE) is implicated in PVR; however, the mechanisms leading to enhanced RPE proliferation, migration, and contraction remain largely unknown. This study utilized an in vitro model of PVR to investigate the role of acetylation in RPE activation and its contribution to the progression of this disease. Methods: ARPE-19 cells, primary cultures of porcine RPE, and induced pluripotent stem cell-derived RPE (iPS-RPE) were utilized for cellular and molecular analyses. Cells treated with transforming growth factor beta 2 (TGFβ2; 10 ng/mL) alone or in the presence of the broad-spectrum histone deacetylase (HDAC) inhibitor, trichostatin A (TSA; 0.1 μM), were assessed for contraction and migration through collagen contraction and scratch assays, respectively. Western blotting and immunofluorescence analysis were performed to assess α-smooth muscle actin (α-SMA) and β-catenin expression after TGFβ2 treatment alone or in combination with TSA. Results: TGFβ2 significantly increased RPE cell contraction in collagen matrix and this effect was inhibited in the presence of TSA (0.1 μM). In agreement with these data, immunofluorescence analysis of TSA-treated iPS-RPE wounded monolayers revealed decreased α-SMA as compared with control. Scratch assays to assess wound healing revealed TSA inhibited TGFβ2-mediated iPS-RPE cell migration. Conclusions: Our findings indicate a role of acetylation in RPE activation. Specifically, the HDAC inhibitor TSA decreased RPE cell proliferation and TGFβ2-mediated cell contraction and migration. Further investigation of pharmacological compounds that modulate acetylation may hold promise as therapeutic agents for PVR.Keywords
This publication has 50 references indexed in Scilit:
- Role of epithelial–mesenchymal transition in proliferative vitreoretinopathyExperimental Eye Research, 2016
- The roles of signaling pathways in epithelial-to-mesenchymal transition of PVR2015
- TGF-β1 Induced Transdifferentiation of RPE Cells is Mediated by TAK1PLOS ONE, 2015
- Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition in retinal pigment epithelium cellsJournal of Cellular and Molecular Medicine, 2014
- Thrombin Induces Epithelial-Mesenchymal Transition and Collagen Production by Retinal Pigment Epithelial Cells via Autocrine PDGF-Receptor SignalingInvestigative Ophthalmology & Visual Science, 2013
- Migration of Retinal Pigment Epithelium Cells Is Regulated by Protein Kinase Cα In VitroInvestigative Ophthalmology & Visual Science, 2013
- Proliferative vitreoretinopathy: current and emerging treatmentsClinical Ophthalmology, 2012
- Fibrosis and diseases of the eyeJournal of Clinical Investigation, 2007
- Smad3 is required for dedifferentiation of retinal pigment epithelium following retinal detachment in miceLaboratory Investigation, 2004
- Proliferative VitreoretinopathySurvey of Ophthalmology, 1998